-41.3%
ALK vs BBIO
+150.9%
-192.2%
-66.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.3% | -0.7% | -5.5% | -6.2% |
| 7D | -12.2% | -2.4% | -9.9% | -11.9% |
| 30D | +3.8% | +15.7% | -11.9% | +1.8% |
| 3M | -17.2% | -3.9% | -13.3% | -16.8% |
| 6M | -1.3% | +16.1% | -17.4% | -3.5% |
| YTD | -27.5% | +0.4% | -27.9% | -28.1% |
| 1Y | -6.8% | +14.8% | -21.6% | -9.1% |
| 3Y | -0.8% | +162.6% | -163.4% | -15.7% |
| 5Y | -31.9% | +66.6% | -98.5% | -50.0% |
| All | -41.3% | +150.9% | -192.2% | -62.9% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling